A clinical trial of ifinatamab deruxtecan in people with advanced esophageal cancer (MK-3475-06F)

Trial Identifier: 3475-06F
Sponsor: Merck
Collaborator:
Daiichi Sankyo
Start Date: March 2026
Primary Completion Date: June 2027
Study Completion Date: June 2028
Condition: Esophageal cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary

Trial Locations

Country Location
China, Beijing Beijing, China, 100142
Czech Republic, Brno-mesto Brno, Brno-mesto, Czech Republic, 565 53
Japan, Aichi Nagoya, Aichi, Japan, 464-8681
Japan, Kanagawa Yokohama, Kanagawa, Japan, 241-8515
Japan, Tokyo Chuo, Tokyo, Japan, 104-0045
Korea, Republic of, Kyonggi-do Goyang-si, Kyonggi-do, Korea, Republic of, 10408
Korea, Republic of, Seoul Seoul, Korea, Republic of, 06351
Korea, Republic of, Seoul Seoul, Korea, Republic of, 05505
Norway, Oslo Oslo, Norway, 0379
Switzerland, Geneve Geneve, Switzerland, 1211
Switzerland, Grisons Chur, Grisons, Switzerland, 7000
Taiwan, Kaohsiung Kaohsiung, Taiwan, 83301
Taiwan, Taichung Taichung, Taiwan, 40447
Taiwan, Tainan Tainan, Taiwan, 704
Taiwan, Taipei Taipei, Taiwan, 11217
Taiwan, Taipei Taipei, Taiwan, 10002
Taiwan, Taipei Taipei, Taiwan, 106
Taiwan, Taoyuan Taoyuan, Taiwan, 33305
Thailand, Songkhla HatYai, Songkhla, Thailand, 90110